Cure8 research brief
The study suggests a colon-targeted herbal treatment altered metabolic and immune pathways and reduced inflammation in a rat model of ulcerative colitis, which could point to new therapeutic approaches to explore for UC treatment.
Researchers studying IBD mechanisms or novel delivery methods, clinicians interested in experimental colon-targeted therapies, and translational scientists focused on metabolism–immune interactions in UC.
This preclinical study tested colon-targeted delivery of a traditional Chinese herbal formulation called Baitouweng decoction (BTW) using transendoscopic enteral tubing (TET) in a DSS-induced rat model of ulcerative colitis.
The authors report that colonic BTW reduced disease activity, preserved mucus and barrier integrity, and shifted metabolite and immune profiles.
Multi-omics and pharmacologic inhibition experiments in the paper link the effect to coordinated changes in arginine and tryptophan metabolic pathways — specifically increased ARG2 expression and higher ornithine/spermidine, plus raised kynurenine/kynurenic acid and AhR signaling — and to improved Treg/Th17 balance and M2-like macrophage responses.
The study is preclinical (rats) and uses mechanistic probes (enzyme inhibitors and metabolite “rescue”) to support involvement of the ARG2–spermidine axis and IDO1–kynurenine–AhR pathway. It suggests TET-mediated local delivery as a possible approach for colon-targeted therapy but does not provide human data.
Preclinical animal study using DSS-induced colitis; results support mechanistic hypotheses but do not provide clinical evidence. TET is a delivery technique evaluated here in animals; human applicability is not established.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This study describes a local rectal therapy that combines mesalamine with probiotic‑derived extracellular vesicles to promote mucosal healing and reduce inflammation in ulcerative colitis models, which could point toward...
Localized rectal delivery of probiotic-derived vesicles combined with mesalamine may offer a way to reduce inflammation and help mucosal healing in ulcerative colitis using a stable, off-the-shelf formulation. This could...
A colon‑targeted delivery system allowed lower, less frequent dosing of an experimental anti‑inflammatory compound in mice and shifted gut microbiota and metabolites linked to colonic health; if translatable, this could...
